World's Best Scientists 2026 revealed!
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
128
Citations
76185
World Ranking
2667
National Ranking
66

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Michele Cavo is affiliated with the University of Bologna in Italy and has a substantial body of work in medical research, particularly focusing on hematology and oncology. Their research spans a variety of fields including Medicine, Biochemistry, Genetics and Molecular Biology, with notable contributions in hematology and molecular biology.

The scientist has a strong emphasis on multiple myeloma research and treatments, protein degradation and inhibitors, and peptidase inhibition and analysis. Additional areas of focus include acute myeloid leukemia, myeloproliferative neoplasms, chronic myeloid leukemia, and chronic lymphocytic leukemia research.

Key recent publications feature studies on multiple myeloma therapies and clinical practice guidelines, including:

  • Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma, 2021, New England Journal of Medicine
  • Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma, 2023, New England Journal of Medicine
  • Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma, 2023, New England Journal of Medicine
  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, 2020, The Lancet Haematology

Michele Cavo frequently co-authors with several researchers in the field, including Meletios Α. Dimopoulos, Philippe Moreau, Elena Zamagni, María-Victoria Mateos, and Mario Boccadoro. Collaborations with these colleagues are reflected in prolific publication records and ongoing contributions to hematological research.

Their work has been published across multiple specialized and high-impact journals, including Blood, Clinical Lymphoma Myeloma & Leukemia, HemaSphere, Journal of Clinical Oncology, and Haematologica. These venues illustrate the broad dissemination and recognition of their research within clinical and molecular hematology communities.

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Nikhil C Munshi;Larry D Anderson;Nina Shah;Deepu Madduri

  • Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Philippe Moreau;Tamás Masszi;Norbert Grzasko;Nizar J Bahlis

  • Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

    Michele Cavo;Paola Tacchetti;Francesca Patriarca;Maria Teresa Petrucci

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Jesús Fernando San Miguel;Jesús Fernando San Miguel;Katja Weisel;Philippe Moreau;Martha Lacy

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

    María-Victoria Mateos;Meletios A. Dimopoulos;Michele Cavo;Kenshi Suzuki

  • Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

    Antonio Palumbo;Roman Hajek;Michel Delforge;Martin Kropff

  • Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

    Lotfi Benboubker;Meletios Athanasios Dimopoulos;Angela Dispenzieri;John Catalano

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types

    Claudio Rapezzi;Giampaolo Merlini;Candida C. Quarta;Letizia Riva

  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P. Moreau;J. San Miguel;P. Sonneveld;M. V. Mateos

  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Michel Attal;Paul G. Richardson;S. Vincent Rajkumar;Jesus San-Miguel

  • IMWG consensus on risk stratification in multiple myeloma

    W J Chng;A Dispenzieri;C-S Chim;R Fonseca

  • Proteasome inhibitors in multiple myeloma: 10 years later.

    Philippe Moreau;Paul G. Richardson;Michele Cavo;Robert Z. Orlowski

  • Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation

    Elena Zamagni;Francesca Patriarca;Cristina Nanni;Beatrice Zannetti

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

Giovanni Martinelli
Giovanni Martinelli University of Bologna
Antonio Palumbo
Antonio Palumbo University of Turin
Michele Baccarani
Michele Baccarani University of Bologna
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Mario Boccadoro
Mario Boccadoro University of Turin
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Sante Tura
Sante Tura University of Bologna
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Francesco Di Raimondo
Francesco Di Raimondo University of Catania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible, cost-effective education, online healthcare degrees open up numerous career opportunities. A popular entry point is exploring medical billing and coding classes online, which prepare you for administrative roles in healthcare without a clinical background.

If you’re considering direct patient care, there are options for aspiring nurses at every level. Students can begin their journeys with the cheapest online nursing program options, teaching essential nursing skills for entry-level positions. Experienced nurses looking to advance their roles and responsibilities may pursue the cheapest online acute care nurse practitioner programs, ideal for those wanting to provide higher levels of care or specialize in acute health settings.

For nurse leaders, educators, and researchers, obtaining top-level credentials is also accessible. The cheapest dnp programs cater to professionals seeking the highest practice-focused degree in nursing—all through online study. These pathways make healthcare professions attainable for more students, regardless of location or schedule.

Best Scientists Citing Michele Cavo

Trending Scientists